Globus Medical, Inc. (GMED)
|52 Week Range||43.39-80.04|
|1y Target Est||-|
|DCF Unlevered||GMED DCF ->|
|DCF Levered||GMED LDCF ->|
|Debt / Equity||12.49%||Neutral|
Upgrades & Downgrades
Latest GMED news
Globus Medical: Merger Overhang Lingering
27 November 2023
Globus Medical, Inc., a mid-cap medical device company, has seen its stock decline by over 35% in 2023 due mainly to its merger with Nuvasive. While the combination gives Globus Medical an over 20% ma...
Globus Medical (GMED) Q3 Earnings Top Estimates, Margins Down
8 November 2023
Globus Medical's (GMED) legacy business continues to drive share growth across its U.S. spine and trauma portfolios in the third quarter.
Globus Medical, Inc. (GMED) Q3 2023 Earnings Call Transcript
7 November 2023
Globus Medical, Inc. (NYSE:GMED ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR Daniel Scavilla - President, CEO & Dir...
Globus Medical (GMED) Reports Q3 Earnings: What Key Metrics Have to Say
7 November 2023
While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metric...
Why Globus Medical (GMED) is Poised to Beat Earnings Estimates Again
6 November 2023
Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
24 October 2023
AUDUBON, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September...
GMED or ABCM: Which Is the Better Value Stock Right Now?
5 October 2023
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Abcam PLC Sponsored ADR (ABCM). But which of these two stocks offers value inves...
Globus Medical: Almost Having My Back
13 September 2023
Globus Medical, Inc. shares have seen a significant pullback after announcing a $3 billion deal to acquire NuVasive. The company has a strong track record in the spine industry and has been outgrowing...
Globus Medical (GMED) Launches NuVasive's NSO in Global Market
8 September 2023
Globus Medical's (GMED) Precice Bone Transport is a less intrusive treatment that reduces complications for both the patient and the surgeon and is designed for various bone abnormalities.